EP 2016061 A1 20090121 - COMPOUNDS WHICH POTENTIATE AMPA RECEPTOR AND USES THEREOF IN MEDICINE
Title (en)
COMPOUNDS WHICH POTENTIATE AMPA RECEPTOR AND USES THEREOF IN MEDICINE
Title (de)
VERBINDUNGEN, DIE DEN AMPA-REZEPTOR VERSTÄRKEN, UND DEREN ANWENDUNG IN DER MEDIZIN
Title (fr)
COMPOSÉS INDUISANT LA POTENTIALISATION DU RÉCEPTEUR AMPA ET LEURS APPLICATIONS EN MÉDECINE
Publication
Application
Priority
- EP 2007054007 W 20070424
- GB 0608272 A 20060426
Abstract (en)
[origin: WO2007122241A1] Compounds of formula (I), and salts and solvates thereof for use as a medicament are provided: (I) wherein R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>4</SUP>, R<SUP>10</SUP>, X and Z are defined in the specification. Processes for preparation, pharmaceutical compositions, and uses thereof as a medicament, for example in the treatment of a disease or condition mediated by a reduction or imbalance in glutamate receptor function, such as schizophrenia or cognition impairment, are also disclosed.
IPC 8 full level
C07D 263/48 (2006.01); A61K 31/421 (2006.01); A61K 31/426 (2006.01); A61K 31/427 (2006.01); A61P 25/00 (2006.01); C07D 277/42 (2006.01); C07D 417/12 (2006.01)
CPC (source: EP)
A61P 25/00 (2017.12); A61P 25/18 (2017.12); A61P 25/28 (2017.12); A61P 43/00 (2017.12); C07D 263/48 (2013.01); C07D 265/30 (2013.01); C07D 277/42 (2013.01); C07D 417/12 (2013.01)
Citation (search report)
See references of WO 2007122241A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
WO 2007122241 A1 20071101; EP 2016061 A1 20090121; GB 0608272 D0 20060607; JP 2009534443 A 20090924
DOCDB simple family (application)
EP 2007054007 W 20070424; EP 07728463 A 20070424; GB 0608272 A 20060426; JP 2009507067 A 20070424